AwardedSpainGoods€2,823,840
Adquisición del medicamento BREYANZI 1,1-70 x 10E6 Células/ML dispersión para perfusión (Lisocabtagen Maraleucel), para el Servicio de Farmacia del Hospital Universitario Ramón y Cajal.
- Published
- Published 24 June 2026
Overview
Hospital Universitario Ramón y Cajal procured the pharmaceutical medication Breyanzi (Lisocabtagen Maraleucel) 1.1-70 x 10E6 Cells/mL dispersion for infusion for its pharmacy service. The award was granted to Bristol Myers Squibb S.A.U. on 28 May 2026 for the contract value of €2,823,840.
Key details
- Country
- Spain
- Status
- Awarded
- Category
- Goods
- Estimated value
- €2,823,840
- Procedure
- Direct
- Published
- 24 June 2026
Antineoplastic agents
Award outcome
- Awarded value
- €2,823,840
- Award date
- 28 May 2026
- BRISTOL MYERS SQUIBB S.A.U.
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
24 June 2026
Contracting authority
HOSPITAL UNIVERSITARIO RAMÓN Y CAJAL
Procuring entityMadrid, Spain
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.